IL174172A0 - Modulators of p-selectin glycoprotein ligand 1 - Google Patents

Modulators of p-selectin glycoprotein ligand 1

Info

Publication number
IL174172A0
IL174172A0 IL174172A IL17417206A IL174172A0 IL 174172 A0 IL174172 A0 IL 174172A0 IL 174172 A IL174172 A IL 174172A IL 17417206 A IL17417206 A IL 17417206A IL 174172 A0 IL174172 A0 IL 174172A0
Authority
IL
Israel
Prior art keywords
modulators
glycoprotein ligand
selectin glycoprotein
selectin
ligand
Prior art date
Application number
IL174172A
Other versions
IL174172A (en
Original Assignee
Abgenomics Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/662,906 external-priority patent/US20040116333A1/en
Application filed by Abgenomics Co filed Critical Abgenomics Co
Publication of IL174172A0 publication Critical patent/IL174172A0/en
Publication of IL174172A publication Critical patent/IL174172A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL174172A 2003-09-15 2006-03-08 Multimeric compound that binds psgl-1 proteins, uses thereof and kits comprising the same IL174172A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/662,906 US20040116333A1 (en) 2001-08-03 2003-09-15 Modulators of P-selectin glycoprotein ligand 1
PCT/US2004/029520 WO2005027831A2 (en) 2001-08-03 2004-09-09 Modulators of p-selectin glycoprotein ligand 1

Publications (2)

Publication Number Publication Date
IL174172A0 true IL174172A0 (en) 2006-08-01
IL174172A IL174172A (en) 2011-12-29

Family

ID=36242362

Family Applications (1)

Application Number Title Priority Date Filing Date
IL174172A IL174172A (en) 2003-09-15 2006-03-08 Multimeric compound that binds psgl-1 proteins, uses thereof and kits comprising the same

Country Status (16)

Country Link
EP (1) EP1663290A4 (en)
JP (1) JP5808879B2 (en)
KR (1) KR101159140B1 (en)
CN (1) CN1852730B (en)
AU (1) AU2004273807B2 (en)
BR (1) BRPI0414402A (en)
CA (1) CA2538284C (en)
EC (1) ECSP066507A (en)
IL (1) IL174172A (en)
NO (1) NO20061306L (en)
NZ (1) NZ546203A (en)
RU (1) RU2407539C2 (en)
SG (1) SG146670A1 (en)
TW (2) TW201012472A (en)
UA (1) UA91004C2 (en)
ZA (1) ZA200602151B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1751300B1 (en) * 2004-05-11 2017-11-08 AbGenomics Coöperatief U.A. T-cell death-inducing epitopes
WO2009139459A1 (en) * 2008-05-15 2009-11-19 国立大学法人 岡山大学 Method for prevention and treatment of metabolic syndrome through the inhibition of psgl-1
CN108713026B (en) * 2016-01-08 2023-01-06 美国全心医药生技股份有限公司 Tetravalent anti-PSGL-1 antibodies and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843707A (en) 1992-10-23 1998-12-01 Genetics Institute, Inc. Nucleic acid encoding a novel P-selectin ligand protein
US6117977A (en) * 1996-04-24 2000-09-12 Genentech, Inc. Type C lectins
ZA973051B (en) * 1996-04-24 1998-10-12 Genentech Inc Type c lectins
US7744888B2 (en) * 2001-08-03 2010-06-29 Abgenomics Cooperatief U.A. Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies

Also Published As

Publication number Publication date
ECSP066507A (en) 2006-10-10
NO20061306L (en) 2006-06-14
TW201012472A (en) 2010-04-01
KR101159140B1 (en) 2012-06-22
RU2006112399A (en) 2006-08-10
JP5808879B2 (en) 2015-11-10
JP2007533618A (en) 2007-11-22
EP1663290A2 (en) 2006-06-07
CA2538284A1 (en) 2005-03-31
RU2407539C2 (en) 2010-12-27
TW200513262A (en) 2005-04-16
ZA200602151B (en) 2013-08-28
AU2004273807B2 (en) 2011-06-09
AU2004273807A1 (en) 2005-03-31
CA2538284C (en) 2015-10-20
IL174172A (en) 2011-12-29
CN1852730B (en) 2012-05-30
CN1852730A (en) 2006-10-25
SG146670A1 (en) 2008-10-30
EP1663290A4 (en) 2009-07-01
UA91004C2 (en) 2010-06-25
NZ546203A (en) 2009-05-31
TWI359024B (en) 2012-03-01
KR20060088104A (en) 2006-08-03
BRPI0414402A (en) 2006-11-14

Similar Documents

Publication Publication Date Title
GB2384570B (en) Modulators
IL173672A0 (en) Separable modulator
IL176215A0 (en) Modulators of muscarinic receptors
PL379551A1 (en) Liquid tooth whitening gel
EP1542063A4 (en) Optical modulator
EP1398252A4 (en) Detachable crawler
GB0120366D0 (en) Nanostructure synthesis
IL158958A0 (en) 5-substituted-2-arylpyridines as crfi modulators
EP1666954A4 (en) Optical modulator
GB0123379D0 (en) Modulators
GB2422544B (en) Immune modulator
AU2002357219A8 (en) Frequency-down-converter using sigma-delta modulators
ZA200602151B (en) Modulators of p-selectin glycoprotein ligand 1
GB0306575D0 (en) Modulators
GB2407131B (en) Modulator
GB2386965B (en) Electro-optic modulators
TW553081U (en) Liquid ornament
GB0302465D0 (en) "13C-labelled synthesis"
GB2408811B (en) Optical Modulator
HK1058002A1 (en) Liquid cosmetics
EP1586282A4 (en) Denture attachment
GB2372577B (en) Electro-optic modulator
HK1058001A1 (en) Liquid cosmetics
GB2397449B (en) Modulator
GB0212773D0 (en) Modulators

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed